Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502856 | SCV000596807 | likely benign | not specified | 2019-12-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000970664 | SCV001118255 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258937 | SCV002533622 | likely benign | Dyskeratosis congenita | 2021-03-24 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002367692 | SCV002666023 | likely benign | Inborn genetic diseases | 2022-07-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001275077 | SCV001459831 | uncertain significance | Dyskeratosis congenita, autosomal dominant 1 | 2020-06-05 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004541567 | SCV004764551 | likely benign | RTEL1-related disorder | 2023-12-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |